Unigestion Holding’s ICU Medical ICUI Stock Holding History

Unigestion Holding’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,100	Closed	-$1.03M	–	246
2019 Q2	$1.03M	Buy	+4,100	New	+$950K	0.03%	184

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Unigestion Holding's ICUI Position: Q3 2019 in Review

Unigestion Holding sold out of ICU Medical (ICUI) in Q3 2019, closing a stake of 4,100 shares — an estimated $1.03M sold.

Unigestion Holding first reported a position in ICUI in Q2 2019 and held it in 1 quarter. The position peaked at $1.03M in Q2 2019. 260 funds tracked by Wall St. Rank hold ICUI as of Q3 2019.

Unigestion Holding reported no remaining ICU Medical position as of Q3 2019 after selling out during the quarter.
Unigestion Holding sold 4,100 ICU Medical shares in Q3 2019, an estimated $1.03M.
Unigestion Holding first reported a position in ICU Medical in Q2 2019 and held it in 1 quarter.
Unigestion Holding's ICU Medical position peaked at $1.03M in Q2 2019.
260 funds tracked by Wall St. Rank held ICU Medical as of Q3 2019.

Based on Unigestion Holding's 13F filing for Q3 2019, filed 4 Nov 2019.